Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is a unique microcap company that is positioned for future growth due to developing tailwinds in system adoption and improved procedural utilization. The company has seen a delay in system sales, but expects to see growth in recurring revenue and catheter sales in the second half of 2021. While there are risks related to technology, IP, and the capital stack, STXS is making progress in its technology and has a strong outlook for future growth.

Bears say

Stereotaxis is a medical device company focused on developing advanced robotic solutions for minimally invasive endovascular procedures, with a core franchise in cardiac electrophysiology. Despite recent regulatory approvals, commercial traction for the company's products has been slow due to manufacturing constraints and low system placements. While there may be potential for growth in the future, current financials and operating results do not show immediate promise, and thus a negative outlook on Stereotaxis's stock is warranted.

Stereotaxis Inc (STXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 4 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.